Basel Medical Group Ltd
BMGL
$4.41
$0.102.32%
NASDAQ
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.97% | -1.83% | |||
| Total Other Revenue | -1.49% | 1,016.67% | |||
| Total Revenue | -0.96% | -1.52% | |||
| Cost of Revenue | -0.97% | 27.83% | |||
| Gross Profit | -0.97% | -32.00% | |||
| SG&A Expenses | -0.96% | 21,608.33% | |||
| Depreciation & Amortization | -0.92% | 0.00% | |||
| Other Operating Expenses | -0.93% | 30.72% | |||
| Total Operating Expenses | -0.97% | 47.60% | |||
| Operating Income | -0.91% | -85.78% | |||
| Income Before Tax | -0.98% | -75.77% | |||
| Income Tax Expenses | 0.96% | -146.03% | |||
| Earnings from Continuing Operations | -0.97% | -43.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.97% | -43.37% | |||
| EBIT | -0.91% | -85.78% | |||
| EBITDA | -1.06% | -85.12% | |||
| EPS Basic | -0.58% | -43.56% | |||
| Normalized Basic EPS | -1.49% | -75.72% | |||
| EPS Diluted | -0.58% | -43.56% | |||
| Normalized Diluted EPS | -1.49% | -75.72% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||